SEARCH

SEARCH BY CITATION

References

  • 1
    Levy E, Rizwan Y, Thibault L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 2000; 71: 80715.
  • 2
    Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992; 52: 41136.
  • 3
    Hardardottir I, Doerrler W, Feingold KR, Grunfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun 1992; 186: 23743.
  • 4
    Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother 2002; 56: 38896.
  • 5
    Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003; 14: 159.
  • 6
    Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121: 54755.
  • 7
    Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 2001; 131: 191827.
  • 8
    Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000; 30: 26074.
  • 9
    Esteve-Comas M, Ramirez M, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992; 33: 13659.
  • 10
    Esteve-Comas M, Nunez MC, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993; 34: 13703.
  • 11
    Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 7415.
  • 12
    Sanderson P, Calder PC. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial dell mono layers. Immunology 1998; 94: 7987.
  • 13
    Usami M, Komurasaki T, Hanada A, Kinoshita K, Ohata A. Effect of gamma-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and/or eicosanoid formation. Nutrition 2003; 19: 1506.
  • 14
    Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170: 26.
  • 15
    Harvey RF, Bradshaw JM. A simple index of Crohn’s disease activity. Lancet 1980; 1: 514.
  • 16
    Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98: 130914.
    Direct Link:
  • 17
    Carnovale E, Marletta L. Tabella di composizione degli alimenti. In: Edra, ed. Table on Feed Chemical Composition. Milan, Italy: Istituto Nazionale della Nutrizione, 1997.
  • 18
    Atlante ragionato di alimentazione. In: ISTITUTO SCOTTI BASSANI per la Ricerca e l’informazione scientifica e nutrizionale, ed. Milano, Italy: 1997.
  • 19
    Southgate DA, Greenfield H. Principles for the preparation of nutritional data bases and food composition tables. World Rev Nutr Diet 1992; 68: 2748.
  • 20
    Roschlau P, Bernt E, Gruber W. Enzymatische bestimmung des gesamtcholesterins im serum. Klin Chem Klin Biochem 1974; 12: 4037.
  • 21
    Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: BergmeyerHU, ed. Methods of Enzymatic Analysis. New York: Academic Press, 1976: 18315.
  • 22
    Lipid Research Clinics Program. Lipid and lipoprotein analysis. In: NIH, ed. Manual of Laboratory Operations, 2nd edn. Washington, DC: US Department of Health and Human Service, 1982: 6377.
  • 23
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 24
    Folch J, Lees M, Stanley GHS. A single method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957; 226: 497507.
  • 25
    Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964; 5: 6008.
  • 26
    Fong Y, Lowry SF. Cytokines and cellular response to injury and infection. In: HarkenAH, WilmoreDW, eds. Care of the Surgical Patient. Sci Am 1996; (Suppl.): 121.
  • 27
    Piquer BR, Nazih H, Bourreille A, et al. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism, 2006; 55: 9808.
  • 28
    Sammalkorpi KT, Valtonen VV, Maury CP. Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins. Ann Med 1990; 22: 397401.
  • 29
    Artl A, Marsche G, Pussinen P, Knipping G, Sattler W, Malle E. Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line. Int J Biochem Cell Biol 2002; 34: 37081.
  • 30
    Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 197202.
  • 31
    Gibney MJ, Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993; 47: 2559.
  • 32
    Geerling BJ, V Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn’s disease, compared with controls. Am J Gastroenterol 1999; 94: 4107.
    Direct Link:
  • 33
    Trebble TM, Arden NK, Wootton SA, et al. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn’s disease. Clin Nutr 2004; 23: 64755.
  • 34
    Trebble TM, Wootton SA, May A, et al. Essential fatty acid status in paediatric Crohn’s disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther 2003; 18: 43342.
  • 35
    Figler M, Gasztonyi B, Cseh J, et al. Association of n-3 and n-6 long-chain polyunsaturated fatty acids in plasma lipid classes with inflammatory bowel diseases. Br J Nutr 2007; 97: 115461.
  • 36
    Geerling BJ, V Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls. Scand J Gastroenterol 1999; 34: 110816.
  • 37
    Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 26571.
  • 38
    Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl 1990; 172: 138.
  • 39
    Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 180611.
  • 40
    De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 182936.
  • 41
    Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997; 400B: 58997.
  • 42
    Chavali SR, Zhong WW, Forse RA. Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 18591.
  • 43
    Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7: 14759.
  • 44
    Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999; 37: 3818.
  • 45
    Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167: 23742.
  • 46
    Bemelmans WJ, Lefrandt JD, Feskens EJ, et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 2004; 58: 10839.
  • 47
    King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003; 92: 13359.
  • 48
    De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000; 71: 213S23S.
  • 49
    Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001; 276: 166839.
  • 50
    Jeppesen PB, Høy CE, Mortensen PB. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Am J Clin Nutr 1999; 70: 7884.